Abstract:Objective To observe the clinical effect of recombinant human type Ⅱ tumor necrosis factor receptor-antibody fusion protein in the treatment of ankylosing spondylitis (AS).Methods Total 80 patients with AS admitted to Nuclear industry 215 Hospital from January 2013 to December 2015 were selected and divided into control group and experiment group by random number table method,with 40 cases in each group.The control group was given Salazosulfapyridine,on basis of control group,the experiment group was given recombinant human type Ⅱ tumor necrosis factor receptor-antibody fusion protein by subcutaneous injection,the course was 3 months.The clinical efficacy of the two groups was observed and compared,the indexes of clinical symptoms of Bath ankylosing spondylitis disease activity index (BASDAI),Bath ankylosing spondylitis functional index (BASFI),joints swelling,morning stiff time in the two groups before and after treatment were recorded.The levels of inflammatory factors of erythrocyte sedimentation rate (ESR),C-reactive protein (CRP),tumor necrosis factor α (TNF-o),interleukin-6 (IL-6),interleukin-8 (IL-8) in the two groups before and after treatnent were detected;and the Schober test,thoracic expansion,neck curland lumbar scoliosiswere detected.The adverse reactions were observed.Results The total effective rate of experiment group was higher than that of control group,the difference was statistically significant (P ＜ 0.05).After treatment,the scores of BASDAI,BASFI in the two groups were lower than those before treatment (P ＜ 0.05),joints swelling degree was decreased (P ＜ 0.05),morning stiff time was shortened (P ＜ 0.05),and the indexes above in the experiment group after treatment were all better than those of control group (P ＜ 0.05).The levels of ESR,CRP,TNF-α,IL-6,IL-8 after treatment in the two groups were all lower than those before treatment,the differences were statistically significant (P ＜ 0.05),and the levels of indexes above after treatment in the experiment group were all lower than those of control group (P ＜0.05).After treatment,the Schober test,thoracic expansion,neck curl,lumbar scoliosis of the two groups were all higher than those before treatment,and the indexes above after treatment in the experiment group were better than those of control group (P ＜ 0.05).There was no significant difference of the incidence of adverse reactions between experiment group and control group (P ＞ 0.05).Conclusion Recombinant human type Ⅱ tumor necrosis factor receptor-antibody fusion protein combined with Salazosulfapyridine in the treatment of AS has better effects,which can significantly promote the improvement of clinical symptoms,decrease the expression of serum inflammatory factors,with high safety,it is worthy of promotion and application.

Treating 38 Cases with Ankylosing Spondylitis by Yaobitong Capsule Coordinating with Acupuncture

ObserVation of warm acupuncture combined with Chinese medicine fumigation in the treatment for actiVity mandatory spondylitis

Efficacy of Yishen Juanbi Oill on Ankylosing Spondylitis

Clinical Study on Rheumatoid Arthritis Treated with Xinfeng Capsule

Value of T2mapping Sequence in the Evaluation on the Efficacy of Etanercept on Ankylosing Spondylitis

Effects of Xinfeng Capsule on Depressive Mood and Serum Cortisol in Patients with Rheumatoid Arthritis

The influence of Xinfeng capsule on pulmanory HRCT images and cytokines in blood serum of adjuvant arthritis rats

[Effect on ankylosing spondylitis at early-middle stage and bone marrow edema of sacroiliac joint treated with acupuncture and governor vessel moxibustion]

Clinical observation of acupoint application of Qin's Daijiu Ointment in treatment of ankylosing spondylitis with syndrome of kidney deficiency and governor vessel cold

Clinical Research of 45 Ankylosing Spondylitis Treated with Integrated Chinese and Western Medicine

[Effect of Xinfeng Capsule on AS Patients and Their Serum Immunoglobulin Subtypes and Peripheral Lymphocyte Autophagy]

Consensus of Chinese Orthopaedic Experts on Diagnosis and Treatment of Ankylosing Spondylitis.

Clinical Efficacy of Etanercept for Treating Ankylosing Spondylitis in 60 Cases

[Clinical study on treatment of patients with ankylosing spondylitis by Panlongqi tablet].

Evaluation on Short-Term Efficacy of Cervus and Cucumis Polypeptide Injection in Treatment of Ankylosing Spondylitis

Clinical Observation on Total Glucosides of Paeony Combined with Sulfasalazine in Treatment of Ankylosing Spondylitis

TREATMENT OF ANKYLOSING SPONDYLITIS BY TRIGEMINAL THERAPY:A Clinical Observation of 120 Cases

A Randomized Trial of Chinese Traditional Health-promoting Exercises for Ankylosing Spondylitis: 212 Board #33 May 31 11

Clinical Study of Xianlinggubao Capsule in the Treatment of Knee Osteoarthritis

Clinical Effect of Recombinant Human Type Ⅱ Tumor Necrosis Factorreceptor-Antibody Fusion Protein in Treatment of Ankylosing Spondylitis

Clinical Study on Erteng Tongbi Mixture Plus Zhengqing Fengtongning Sustained Released Tablet in the Treatment of Rheumatoid Arthritis:A Report of 30 Cases